More Articles

EGA: Biosimilars essential for generics industry as well Conferences | Posted 01/09/2009

Would-be big generics players will have to move into biosimilars, Ms Francesca Bruce of Scrip News heard at the European Generic medicines Association (EGA) conference recently held in Barcelona, S...

EGA meeting Barcelona 2009: Will size matter in the generics space? Conferences | Posted 01/09/2009

The generic medicines market is getting tougher and players of all sizes will find it harder to compete, but there are opportunities for both big and small firms, Ms Francesca Bruce of Scrip News h...

EGA meeting Barcelona 2009: commoditisation risks sustainability of generic medicines market Conferences | Posted 01/09/2009

The commoditisation of generic medicines markets could be a real threat to the sustainability of the industry, Ms Francesca Bruce of Scrip News heard at the European Generic medicines Association's...

Glycosylation main approval issue with biosimilars Conferences | Posted 01/09/2009

Post-translational modifications (PTMs), particularly glycosylation, will play a critical role in how biosimilars – also called follow-on biologics or biogenerics – and will eventually be approved...

Building trust in biosimilars main challenge of EGA Conferences | Posted 01/09/2009

So far, three types of biosimilar medicines have been approved in the EU – somatropin (human growth hormone, hGH), epoetin (erythropoietin, EPO) and filgrastim (granulocyte colony-stimulating facto...

DIA EuroMeeting: EU needs automatic pricing to get generics to market Conferences | Posted 01/09/2009

“The EU needs greater regulatory capacity and automatic pricing and reimbursement to deal with the number of generics required to serve the market”, said Mr Georg Stark, Joint Managing Director of...

Teva looking for ‘major’ acquisition Generics/News | Posted 31/08/2009

Just a year after swallowing the US$7.4 billion (Euros 5.3 billion) Barr Laboratories buy, Teva Pharmaceutical Industries is ready for another ‘major’ acquisition and may look beyond generic drugs...

WHO has prequalification multisource (generic) guideline Policies & Legislation | Posted 31/08/2009

On 18 June 2009, WHO published a Prequalification Update, informing that a guideline on submission of documentation for prequalification of multisource (generic) has been completed and that Finishe...